Navigation Links
Pharmaceutical Executive Magazine's 2013 Drug "Brand of the Year" Awarded to Leading Merck Diabetes Drug Januvia
Date:3/26/2013

NEW YORK, March 26, 2013 /PRNewswire/ -- Pharmaceutical Executive, the monthly magazine and daily online publication of record on analytics, trends and personalities in the biopharmaceutical industry worldwide, announced today the choice for its 2013's drug Brand of the Year: Merck's Januvia [sitagliptin], a first in class dipeptide peptidase-4 inhibitor treatment for adult onset [Type II] diabetes.    

Brand of the Year is an independent, non-promotional designation, selected annually since 1998 by the publication's editorial staff and expert Advisory Board. It seeks to recognize FDA-authorized prescription medicines with a track record of clinical innovation as well as consistent, real-world performance and appeal to patients. It must also demonstrate novelty in the developer's approach to brand-building and market awareness activities.

Januvia was developed and has been marketed by Merck since 2006, and, along with its sister drug Janumet, is now the biggest-selling therapeutic franchise in the company's 122 year history.  "We are pleased to devote our March cover to this important medicine, not only because of its breakthrough status in regulating blood sugar among Type II patients, with fewer side effects, but also for the higher profile it has given to a debilitating chronic condition that contributed to the deaths of more than 4.6 million people worldwide in 2011," said Pharm Exec Editor-in-Chief William Looney .

The story, authored by Senior Editor Ben Comer , features interviews and backgrounders with several top Merck executives, representatives of the original product launch team, patient groups and independent medical experts, all of whom point to the need for further progress by the pharmaceutical industry in combating persistent challenges in managing this growing illness &
'/>"/>

SOURCE Pharmaceutical Executive
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
2. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
3. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
4. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
5. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
6. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
7. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
8. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
9. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
10. Icahn Issues Statement Regarding Amylin Pharmaceuticals
11. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... FLORHAM PARK, N.J. , Aug. 21, 2014 ... specialty pharmacy group purchasing organization (GPO), is pleased ... (Aurora) to collaborate on a host of innovative ... will help Aurora deliver enhanced therapy management services ... Therapy Management (OTM) system. Aurora will ...
(Date:8/21/2014)... 21, 2014 CVS Caremark Corporation (NYSE: ... Yields and consideration payable in connection with its previously announced ... 2014 for (1) any and all of its 6.250% Senior ... up to a maximum amount of its 6.125% Senior Notes ... Notes due 2017 (collectively, the "Maximum Tender Offer Notes" and ...
(Date:8/21/2014)... 21, 2014 Professional Compounding Centers of ... by awarding the three best scientific presentations at ... conference . The Formulating Better Medicines for ... Athens, Greece , includes dozens ... professionals, from which three winners will be selected ...
Breaking Medicine Technology:Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients 2Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients 3CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 2CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 3CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 4CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 5CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 6Professional Compounding Centers of America will award top poster-session winners at European Paediatric Formulation Initiative in Athens 2
... THE WOODLANDS, Texas, Aug. 9, 2011 ... ), a biopharmaceutical company focused on discovering breakthrough ... data from its recently completed Phase 2 study ... etiprate. Carcinoid syndrome is a chronic condition caused ...
... SAN DIEGO and WOODCLIFF LAKE, N.J., Aug. 9, 2011 ... and Eisai Inc. announced today results from ... mammary tumor diagnoses from a two-year rat carcinogenicity study ... the lorcaserin Complete Response Letter (CRL), which questioned the ...
Cached Medicine Technology:Phase 2 Trial of Lexicon's LX1032, Telotristat Etiprate, Shows Positive Results in Carcinoid Syndrome 2Phase 2 Trial of Lexicon's LX1032, Telotristat Etiprate, Shows Positive Results in Carcinoid Syndrome 3Phase 2 Trial of Lexicon's LX1032, Telotristat Etiprate, Shows Positive Results in Carcinoid Syndrome 4Phase 2 Trial of Lexicon's LX1032, Telotristat Etiprate, Shows Positive Results in Carcinoid Syndrome 5Arena and Eisai Announce Results of Re-Adjudication of Rat Mammary Tumors from Lorcaserin Carcinogenicity Study 2Arena and Eisai Announce Results of Re-Adjudication of Rat Mammary Tumors from Lorcaserin Carcinogenicity Study 3Arena and Eisai Announce Results of Re-Adjudication of Rat Mammary Tumors from Lorcaserin Carcinogenicity Study 4Arena and Eisai Announce Results of Re-Adjudication of Rat Mammary Tumors from Lorcaserin Carcinogenicity Study 5Arena and Eisai Announce Results of Re-Adjudication of Rat Mammary Tumors from Lorcaserin Carcinogenicity Study 6
(Date:8/21/2014)... The world wound care market is ... and reach USD 18.3 billion by 2019, posting a ... of such growth include governments’ contribution to the development ... and surging ageing population. However, the growth could be ... Region-wise, North America leads the global wound care market, ...
(Date:8/21/2014)... 2014 Revista, a one-stop source ... industry-focused data, is “on a roll.” Today, the ... on the Southeast, Mid-Atlantic and Midwest areas of ... first widely available, comprehensive medical property database tracking ... searchable properties, including existing and recently added, is ...
(Date:8/21/2014)... two types of polio vaccines seems to provide stronger ... eradicate polio, a new study shows. The research ... the Salk inactivated poliovirus vaccine (IPV) to those who ... vaccine (OPV) appeared to improve their immunity to the ... the Aug. 22 issue of the journal Science ...
(Date:8/21/2014)... The American College of Chest Physicians (CHEST) announces ... Ill and Injured During Pandemics and Disasters: CHEST ... of the journal CHEST while the ... Ebola virus. The consensus statement aims to guide ... research in crises. The statement was developed by ...
(Date:8/21/2014)... 2014Popular fiction that normalizes and glamorizes violence against women, ... associated with a greater risk of potentially harmful health ... study are presented in the article " Fiction or ... Adolescent and Young Adult Females ," published in ... Mary Ann Liebert, Inc., publishers . The article ...
Breaking Medicine News(10 mins):Health News:Global Wound Care Market to Post 3.2% CAGR Through 2019, Says MarketsandMarkets in Its New Report Published at MarketPublishers.com 2Health News:Global Wound Care Market to Post 3.2% CAGR Through 2019, Says MarketsandMarkets in Its New Report Published at MarketPublishers.com 3Health News:Revista Medical Property Data Now Available for the Mid-Atlantic, Southeast and Midwest Regions 2Health News:Revista Medical Property Data Now Available for the Mid-Atlantic, Southeast and Midwest Regions 3Health News:Revista Medical Property Data Now Available for the Mid-Atlantic, Southeast and Midwest Regions 4Health News:Revista Medical Property Data Now Available for the Mid-Atlantic, Southeast and Midwest Regions 5Health News:Two Polio Vaccines May Give Greater Protection Against Crippling Disease 2Health News:CHEST releases new expert guidance in care of the critically ill and injured 2Health News:Women's health and Fifty Shades: Increased risks for young adult readers? 2
... breakfast and lunch lose less weight compared to those who ... by researchers at Fred Hutchinson Cancer Research Center., The results ... a member of the Hutchinson Center,s Public Health Sciences Division ... the December issue of the Journal of the American ...
... researchers at Tel Aviv University have discovered that the two ... that movement and their survival. Fungal spores can ... travel. And while this allows them to travel further than ... TAU,s Raymond and Beverly Sackler School of Physics and Astronomy, ...
... 28 (HealthDay News) -- ,Heart function improved in obese people ... a small new study says. Researchers measured body-mass index ... fat in 15 obese people (seven men and eight women) ... started consuming a 500-calorie-per-day diet. Pericardial fat collects around ...
... a person with mild cognitive impairment is agitated or restless, ... well. According to research conducted at Virginia Tech, the more ... their loved one, the more they find themselves unable to ... This heightens the effect of elevated stress levels on their ...
... Foundation received two government grants to study the ... the rehabilitation and reintegration of people with spinal ... to Denise Fyffe, PhD, a research scientist in ... Fyffe, a clinical psychologist, is an expert in ...
... , SUNDAY, Nov. 27 (HealthDay News) -- Socializing ... people find it difficult. If you suffer anxiety or ... from Martin Antony, a psychology professor at Ryerson University in ... make eye contact. Be approachable and open to conversation. Join ...
Cached Medicine News:Health News:Mid-morning snacking may sabotage weight-loss efforts 2Health News:Mid-morning snacking may sabotage weight-loss efforts 3Health News:Fungi: Another tool in bacteria's belt? 2Health News:Low-Cal Diet Cuts Fat Around Heart in Obese People: Study 2Health News:Caregivers at risk for health problems 2Health News:Kessler Foundation receives grants to study health disparities in people with disabilities 2Health News:Surviving Holiday Parties When You Have Social Anxiety 2
... Bulb Direct has been selling ... since 1996, and we are ... satisfaction guarantee. Check out our ... see our discount light bulbs ...
... Bulb Direct has been ... Internet since 1996, and we ... 100% satisfaction guarantee. Check out ... and see our discount light ...
... Direct has been selling replacement ... 1996, and we are extremely ... guarantee. Check out our catalog ... our discount light bulbs specials. ...
... Bulb Direct has been ... Internet since 1996, and we ... 100% satisfaction guarantee. Check out ... and see our discount light ...
Medicine Products: